Cadila Pharmaceuticals marks three years of ThRabis, a three-dose rabies vaccine EP News Bureau Apr 25, 2025 ThRabis rollout sees increased vaccine compliance and reduced treatment burden across multiple regions
Cadila Pharma’s rabies vaccine ‘ThRabis’ receives award at Golden Globe Tigers Awards EP News Bureau May 22, 2023 ThRabis is a three-dose recombinant nanoparticle-based rabies G protein vaccine
Cadila Pharma launches world’s first novel three-dose rabies vaccine ThRabis EP News Bureau Apr 11, 2022 The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology
